These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28320011)

  • 1. Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation.
    Ong MS; Mandl KD
    Ann Intern Med; 2017 Mar; 166(6):451-452. PubMed ID: 28320011
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.
    Catalona WJ; D'Amico AV; Fitzgibbons WF; Kosoko-Lasaki O; Leslie SW; Lynch HT; Moul JW; Rendell MS; Walsh PC
    Ann Intern Med; 2012 Jul; 157(2):137-8. PubMed ID: 22801676
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
    Ann Intern Med; 2012 Jul; 157(2):I-44. PubMed ID: 22801691
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Taneja SS
    J Urol; 2016 Feb; 195(2):350-1. PubMed ID: 26852972
    [No Abstract]   [Full Text] [Related]  

  • 6. State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
    Vetterlein MW; Dalela D; Sammon JD; Karabon P; Sood A; Jindal T; Meyer CP; Löppenberg B; Sun M; Trinh QD; Menon M; Abdollah F
    Urology; 2018 Feb; 112():56-65. PubMed ID: 29056579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.
    Albertsen PC
    Eur Urol; 2013 Sep; 64(3):512. PubMed ID: 23915461
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in Prostate-Specific Antigen Screening Since the Implementation of the 2012 US Preventive Services Task Force Recommendations.
    Rahbar H; Karabon P; Menon M; Trinh QD; Abdollah F
    Eur Urol Focus; 2018 Dec; 4(6):1002-1004. PubMed ID: 28753856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Changes in Prostate Cancer Screening Practices and Epidemiology.
    Lee DJ; Mallin K; Graves AJ; Chang SS; Penson DF; Resnick MJ; Barocas DA
    J Urol; 2017 Dec; 198(6):1230-1240. PubMed ID: 28552708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2008 Aug; 149(3):185-91. PubMed ID: 18678845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States.
    Kim SP; Karnes RJ; Gross CP; Meropol NJ; Van Houten H; Abouassaly R; Shah ND
    Urology; 2016 Nov; 97():111-117. PubMed ID: 27527411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen testing: men's responses to 2012 recommendation against screening.
    Squiers LB; Bann CM; Dolina SE; Tzeng J; McCormack L; Kamerow D
    Am J Prev Med; 2013 Aug; 45(2):182-9. PubMed ID: 23867025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
    Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
    Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
    Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
    BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. Screening for prostate cancer: a recommendation from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2002 Dec; 137(11):I48. PubMed ID: 12459001
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations.
    Sammon JD; Abdollah F; Choueiri TK; Kantoff PW; Nguyen PL; Menon M; Trinh QD
    JAMA; 2015 Nov; 314(19):2077-9. PubMed ID: 26575066
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New US Preventive Service Task Force recommendations for prostate cancer screening: a needed update, but not enough.
    Wroclawski ML
    Einstein (Sao Paulo); 2017; 15(3):7-10. PubMed ID: 29091165
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change?
    Van der Kwast TH; Roobol MJ
    Nat Rev Urol; 2017 Aug; 14(8):457-458. PubMed ID: 28607501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.